Qube Research & Technologies Ltd

Position in ACRS — Aclaris Therapeutics, Inc.

CIK 1729829 LONDON, X0

Position in ACRS

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$729,412

-$616,584 QoQ

Shares Held

194,510

-56.5% QoQ

Ownership

0.139%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2020

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Qube Research & Technologies Ltd holds $2,030,593,180 across 187 Biotechnology names. ACRS ranks #129 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	838,187	$277,330,932
2	FOLD	AMICUS THERAPEUTICS, INC.	8,809,340	$127,383,056
3	ROIV	Roivant Sciences Ltd.	3,450,904	$95,590,040
4	RPRX	Royalty Pharma plc	1,524,511	$73,130,792
5	REGN	Regeneron Pharmaceuticals, Inc.	83,358	$64,405,725
6	AXSM	Axsome Therapeutics, Inc.	335,334	$56,678,152
7	RVMD	Revolution Medicines, Inc.	553,290	$53,807,452
8	CYTK	Cytokinetics Inc	779,446	$51,373,285

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$729,412	194,510	-56.5%	Shares	Sole	2026-05-15
2025-12-31	$1,345,996	447,175	-17.9%	Shares	Sole	2026-02-17
2025-09-30	$1,035,044	544,760	+7.0%	Shares	Sole	2025-11-14
2025-06-30	$723,277	509,350	-62.3%	Shares	Sole	2025-08-14
2025-03-31	$2,066,754	1,350,820	+119.6%	Shares	Sole	2025-05-15
2024-12-31	$1,525,405	615,083	+110.0%	Shares	Sole	2025-02-14
2024-09-30	$336,771	292,845	-68.9%	Shares	Sole	2024-11-14
2024-06-30	$1,034,826	940,752	-22.4%	Shares	Sole	2024-08-14
2024-03-31	$1,503,202	1,212,260	-27.8%	Shares	Sole	2024-05-14
2023-12-31	$1,763,900	1,679,905	+9786.4%	Shares	Sole	2024-02-13
2020-12-31	$109,938	16,992	—	Shares	Sole	2021-02-16
No filing history on record for this holder in this stock.